In Vitro Diagnostics (IVD) are the medical devices, accessories, instruments, reagents and systems deployed to perform medical test on samples (e.g., blood, urine and tissue taken from human body) to diagnose diseases, detects infections, diagnose medical conditions, monitor drug therapies, prevent diseases. Some tests usually performed in authorized laboratories by the trained healthcare professionals and some tests can be done at home. Devices may range from simple tests to sophisticated DNA technology including calibrators, control materials, kits, reagents, software, or related instruments. IVD is an important segment in the global healthcare industry. The marketplace is witnessed rapid growth supported by advancements in technologies, evolvement of new tools, improvement in disease monitoring, higher demand of OTC tests, increased prevalence of infectious and other diseases like oncology, cardiovascular etc. IVD products are classified into Class I, III and III by FDA regulations to assure their safety and effectiveness.
International Conference on In Vitro Diagnostics | Sep 03-04 | 2018 | London | UK | IVD Confereces | IVD Meetings | IVD Workshops | IVD Presentations | IVD instruments |US IVDs | CDx | VD Technology | diagnostics technologies | in vitro diagnostic research | in vitro diagnostic development | in vitro diagnostic manufacturers | point of care testing | in vitro diagnostics | clinical laboratory tests | assay system components | Medical Devices | Biomedical devices | Biomedical technologies | In vitro diagnostic multivariate index assay | Protein biomarkers | IVDMIA | IVD group | Who Global Model Regulatory Framework | Medical Devices | in Vitro Diagnostic Medical Devices | Who Medical Device | Immunochemistry Assay Development | Assay Development Service | Bioanalytical applications | Biomarkers | Biosensors | Blood gas analyser | Blood Glucose Meters | Blood Screening | Immunochemistry Assay Development | Assay Development Service | Bioanalytical applications | Biomarkers | Biosensors | Blood gas analyser | Blood Glucose Meters | Blood Screening | CE mark for IVD | Circulating tumor cell (CTC) | Clinical Evidence | Clinical Instruments | Clinical Microbiology | Compaliance | Companion Diagnostics | Custom Antibody | Data Management | Diagnosis | Diagnotics | Digital PCR | DNA testing | Enzyme Linked Immunosorbent Assay (ELISA) | Gene Diagnostics | Genetic Testing | Haematological diagnostics | Haemoglobin Meters | Hematological Diagnosis | Immuno assay | Immunoassay | Immunochemical labeling kits | In Vitro Diagnostics | In vitro diagnostics applications | In Vitro Diagnostics Devices | In vitro diagnostics Manufacturing | In vitro diagnostics technology | In Vitro diagnostics tests | Industry Classification | IVD Classifications | IVD Design | IVD devices | IVD Instruments | IVD Manufacturers | IVD Market Drivers | IVD Market Intelligence | IVD Market Landscape | IVD Market Reports | IVD Market Statistics | IVD Reagents | IVD Regulation | IVD Tests | IVDS | Lab | on | a | chip | Lateral flow assays | Liquid biopsy | Microarray technology | Microfluidics | Mobile healthcare | Molecular assays | Molecular Diagnostics | Nanomaterial | based assays | Next | generation sequencing (NGS) | Noninvasive prenatal testing (NIPT) | Oncology Diagnosis | Paper | based assays | Patient self | testing | PCR | POCT | Point of Care Diagnostics | Point | of | care | Post Market Surveillance | Precision Medicine | Primary antibodies | Q PCR | Quality Control | Quality system in IVD | Radioimmunoassay | Reagents | Regulatory affair | Secondary antibodies | Sepsis markers | Signal enhancement | Smartphone | based devices | Stroke markers | Surface plasmon resonance | UDI implementation | UL mark for IVD | Companion Diagnostics | Disease detection | Disease diagnosis | Disease prevention | DNA Microarrays | DNA testing | Electrochemistry | ELISA | Exosomes | Gene Expression | Genetic testing | Haematological diagnostics | Immuno assay | Immunoassays | In Vitro Diagnostics | In Vitro diagnostics tests | Infectious disease | IVD | Liquid biopsy | Micro Array | Molecular assays | Molecular assays | Molecular Diagnostics | NGS | PCR | POCT | Point of Care Diagnostics | RT PCR | Screening | IVD Product Manufacturers | Group Purchase Organizations (GPOs) | Original Equipment Manufacturers (OEM) | Pathologists and Pathology Laboratories | Distributors of IVD Products | Hospitals and Clinics | Healthcare Institutions | Research Institutes | Market Research and Consulting Firms | Reagents & Kits | Instruments | Services | Data Management Software | Clinical Chemistry | Basic Metabolic Panel | Electrolyte Panel | Liver Panel | Lipid Profile | Renal Profile | Thyroid Function Panel | Specialty Chemical Tests | Immunochemistry/Immunoassay | Enzyme-Linked Immunosorbent Assay (ELISA) | Chemiluminescence Immunoassay (CLIA) | Fluorescence Immunoassay (FIA) | Colorimetric Immunoassay (CI) | Radioimmunoassays (RIA) | Rapid Tests | Western Blot | ELISPOT | Hematology | Coagulation & Hemostasis | Clinical Microbiology | Molecular Diagnostics (MDx) | Polymerase Chain Reaction (PCR) | Isothermal Nucleic Acid Amplification Technology (INAAT) | Microarrays | Hybridization | DNA Sequencing & Next-generation Sequencing | Other MDx technologies | Other Technologies | Global In Vitro Diagnostics Market | by Application | Diabetes | Infectious Diseases | Oncology/Cancer | Cardiology | Nephrology | Autoimmune Diseases | Drug Testing | HIV/Aids | Other Applications | Global In Vitro Diagnostics Market | by End User | Hospitals | Laboratories | Academic Institutes | Point-Of-Care Testing | Patient Self-Testing | End Users | immunoassays | point of care | molecular diagnostics | hematology | coagulation | microbiology | clinical techniques | microbiology | nstruments | reagents | services | data management systems | diabetes | oncology | cardiology | HIV/AIDS | autoimmune disease | nephrology | drug testing | IVD market | clinical laboratory testing | near-patient testing | self-testing | Prognosis of prediabetes and diabetes | Prediction of gestational diabetes | Treatment selection and monitoring | Guide development of islet sparing | disease-modifying drugs | Companion diagnostics | Direct assessment of pancreatic islet health | Improved efficiency and convenience compared to oral glucose test | Measurements complementary to glycemia | Early diagnosis of pheochromocytomas and other NET in plasma. | Accurate prognostic assessment | in vitro diagnostics | immunoassays | lateral flow assays | nanomaterial-based assays | biomarkers | lab-on-a-chip | microfluidics | electrochemistry | biosensors | signal enhancement | surface plasmon resonance | microarrays | paper-based assays | smartphone-based devices | mobile healthcare | point-of-care | bioanalytical applications | Antigen | AP (Alkaline Phosphatase) | Array | Assay diluent | Assay sensitivity | BCIP | Blocking | Blotting | Chemiluminescent substrate | Clinical sensitivity | Clinical specificity | Colorimetric substrate | Conjugate | Cross-reactivity | Detection limit | Diagnostic assay | Dilution | Dynamic range | ELISA (Enzyme-Linked ImmunoSorbant Assay) | Enzyme | Heterophilic interference | HRP (Horseradish Peroxidase) | Immunoassay | Immunoblotting | Immunohistochemistry | In situ hybridization (ISH) | Interference | IVD (In Vitro Diagnostics) | Matrix effect | Membrane | Microwell | Molecular diagnostics | Multiplexing | Non-specific binding | Passivating surface chemistry | pNPP | Protein stabilizers | Rheumatoid factor | Sample matrix interference | Signal | Substrate | Test performance | TMB | Western Blot | ID/AST Test | Auto ID | AST Systems | Manual ID | AST Systems | Blood Culture | Chromogenic Media | Rapid Micro,ID/AST Leader Market | Infectious Disease Immunoassays | Lab-Based | POC | Home Testing | Laboratory Infectious Disease | Immunoassays Sales by Disease,Hepatitis | HIV | Mycology | Parasitology | Respiratory | Sepsis | STDs | ToRCH | Infectious Disease Diagnostic Sales– North America | Western Europe | Japan | China | India | Latin America | ROW | Blood Screening Test Market Size and Company Market Share | Worldwide Cancer Diagnostic Market | Global Cancer IVD Market | Clinical Laboratory Services | Marketing Screening Tests for Prostate Specific Antige | Regulatory Strategy Expertise | FDA Negotiation | Clinical Trial Protocol Development | Clinical Site Recruitment | Clinical Trial Management | Statistical Planning and Analysis | Final Clinical Trial Reports | Regulatory Submissions | Quality Manufacturing Audits | Broad Selection of Clinical Diagnostic Analyzers | Abbott IMX | Abbott AxSym Plus | Abbott Architect | | Roche ElecySys 2010 | Siemens/Dade RXL | Tosoh AIA-600-II | Complement of Molecular Diagnostic Techniques | Full suite of CLSI Testing required by FDA-OIVD | IVD Test Technology Evaluation & Optimization | IVD Test Development & Optimization | Association of Medical Diagnostic Manufacturers | American Association for Clinical Chemistry | U.S. Food and Drug Administration | Clinical and Laboratory Standards Institute | Cancer Markers & PGx | Histology (In situ hybridization | HPV) | Microbiology/Virology (HAI; HIV; Hepatitis; GC/Chlamydia; Respiratory;Organism ID; Mycobacteria | TB; Others) | Blood Screening | Coagulation & PGx | Prenatal Testing | Inherited Diseases Testing | Tissue Typing | Organ Transplant Testing (HLA Typing) | Circulating Tumor Cells (CTCs) | Clinical Sequencing | Flow Cytometry | Cancer IVD Market | Cancer Test Services Market | Sequencing in Cancer Testing | Tissue Function Tests | PSA | CEA and Other Immunoassays | Flow Cytometry | Pap and HPV Testing | FOB and Other Rapid Tests | Molecular Oncology Assays | Tissue Microarrays | Methylated DNA | In situ hybridization (ISH) | Immunohistochemistry (IHC) | Circulating Tumor Cells | Companion Testing and CDX Products | Chromosome Analysis (Karyotyping) | Cytology/Histology Stains | Tests for Fecal Occult Blood | Immunoassays | Overview - Immunoassays | Immunoassay Instrument Platforms | Immunohistochemistry (IHC) | Flow Cytometry | Fluorescence in situ Hybridization (FISH) and Chromogenic in situ Hybridization(CISH) | Nucleic Acid Amplification Technologies | Analysis of Gene Expression Patterns (Gene Signatures) | Microarrays | Protein Microarrays | DNA Microarrays | Chromosomal Microarrays | Tissue Microarrays | Sequencing Technologies | Sanger Sequencing | Early Next Generation Sequencing Technologies | Sequencing by Synthesis (SBS) | Supported Oligonucleotide Ligation and Detection (SOLiD) | Ion Torrent Sequencing | True Single Molecule Sequencing (tSMS) | Single Molecule Real Time (SMRT) Sequencing | DNA Nanoball Sequencing | Nanopore Sequencing | Other Sequencing Technologies | Mass Spectrometry | Mass Spectrometry Technology | Research and Clinical Applications of Mass Spectrometry | Circulating Tumor DNA (Cell Free DNA) | Circulating Tumor Cells (CTCs) | Cell-Based Assays (Live Cell Cancer Tests) | Digital Pathology and Image Cytometry | Information Technology | Assess Risk of Developing Cancer | Cancer Screening | Cancer Screening – Pap Smear and Human Papillomavirus (HPV) Testing | Colorectal Cancer Screening | Prostate Cancer Screening | Screening for Other Cancers | Diagnosis/Prognosis/Monitoring of Cancer | Personalized Medicine/Companion Diagnostics/Precision Testing | Drug Metabolism | Predicting Response to Therapy | FIVE: CANCER DIAGNOSTIC MARKETS | In Vitro Diagnostic Kits Marketed to Clinical Laboratories | Point-of-Care Tests for Cancer | Clinical Laboratory Test Services | Investments and Financing Agreements for Cancer Diagnostic Companies | Agreements with Other Companies | Acquisitions of Cancer Diagnostic Companies | Selected Other Agreements | Cancer Diagnostic Market Drivers | Advances in Technology Changing the Future of Cancer Diagnostics | Impact of Companion Diagnostic Tests | Limited Tissue from Biopsies for Growing Number of Cancer Tests | Laboratory Developed Tests and the FDA | Cost and Reimbursement Issues | Physician Education | Acceptance | and Use of New Cancer Tests | Competition | Future Prospects | In Vitro Cancer Diagnostics Market by Geographical Distribution | Clinical Laboratory Testing Market – Cancer Diagnostics | In Vitro Cancer Diagnostics Market Segments | Histology/Cytology | Immunoassays | Rapid Tests | Molecular (Nucleic Acid-Based) Assays | M Genomics Ltd. | 20/20 GeneSystems | Inc. | AB SCIEX | Abbott Laboratories | Abcodia Ltd. | Abingdon Health Ltd | Abnova Corporation | ACT Genomics Co. | Ltd. | Adaptive Biotechnologies Corporation | Admera Health (a GENEWIZ company) | Advanced Cell Diagnostics | Affymetrix | Inc. | Agena Bioscience Inc. | Agendia NV | Agilent Technologies Inc. | Alere Inc. | Ambry Genetics Corp. | Amoy Diagnostics Co. | Ltd. | ANGLE plc | ApoCell | Inc. | Applied Proteomics | Inc. | Applied Spectral Imaging | Inc. | Arbor Vita Corporation | ARKRAY | Inc. | ARUP Laboratories | Astra Biotech GmbH | Asuragen | Inc. | AsymmetRx Medical | Inc. | Atossa Genetics Inc. | AutoGenomics | Inc | Avant Diagnostics | Inc. (formerly Arrayit Diagnostics Inc.) | Axela | Inc | AXO Science | Beckman Coulter | Inc. (subsidiary of Danaher Corporation) | Becton | Dickinson and Company (BD) | BGI-Shenzhen | The Binding Site Group Ltd. | Biocare Medical | LLC | Biocartis SA | Biocept | Inc. | Biodesix | Inc. | BioFluidica | BioGenex | Biological Dynamics Inc. | BioMarker Strategies | bioMérieux SA | BioMosaics | Bio-Rad Laboratories | Inc. | Bio-Reference Laboratories | Inc. (BRLI) | BioSystems | bioTheranostics (a bioMérieux company) | Biotype Diagnostic GmbH | BioView Ltd | Boditech Med Inc. | Cancer Genetics | Inc. | Canopus Bioscience Ltd. | Caprion | Inc. | Caris Life Sciences | Castle Biosciences | Inc. | CDx Diagnostics | Celerus Diagnostics | Inc. | Cellmid Ltd. | Centogene AG | Cepheid | Cernostics | Cirdan Imaging Ltd | Clarient Diagnostic Services | Inc. (a GE Healthcare company) | Clearbridge BioMedics Pte Ltd | Color Genomics | Inc. | Counsyl | Inc. | Cube Dx GmbH | Cynvenio Biosystems | Inc. | CytoTest Inc. | Dako A/S (an Agilent company) | Danaher Corporation | DermTech | Inc. | DiaCarta | Inc. | DiaSorin S.p.A. | DiaTech Oncology | EDP Biotech Corporation | Eiken Chemical Co. | Ltd. | EntroGen | Inc. | Enzo Biochem | Inc | Enzo Life Sciences | Inc. | Enzo Clinical Labs | Inc. | Epic Sciences | Inc. | Epigenomics AG | Eutropics Pharmaceuticals | Exact Sciences Corporation | Exosome Diagnostics | Inc. | Fluxion Biosciences | Inc. | Foundation Medicine | Inc. | Fujirebio Inc. | Fujirebio Diagnositics | Inc. | GE Healthcare | Genalyte | Inc. | GeneCentric Diagnostics | Inc. | Genection | Inc. (an Invivoscribe company) | GeneDx | GeneNews Limited | Genetic Technologies Limited / Phenogen Sciences | Inc. (U.S. division) | GenomeDx Biosciences | Genomica S.A.U. | Genomic Health | Inc. | Genomic Vision | Genoptix (a Novartis company) | GenPath / GenPath Women’s Health and GenPath Oncology | Guardant Health | Inc. | HalioDx | Healgen Scientific LLC | Helomics Corporation | Hologic | Inc. | HTG Molecular Diagnostics | Inc. | Human Longevity | Inc. | Icellate AB | Ikonisys | Inc. | Illumina | Inc. | ImCare BioTech | Immunovia AB | IncellDx | Inc. | Inform Genomics | Inc. | Financings | Other Agreements | Inivata Ltd. | Innovations Exchange Pte Ltd (INEX) | Insight Genetics | Inc. | IntegraGen SA | Integrated Diagnostics | Inc. | Invitae Corporation | Invivoscribe Technologies | Inc. | Iris BioTechnologies Inc. | Janssen Diagnostics / Janssen Diagnostics BVBA | Janssen Diagnostics | LLC | Laboratory Corporation of America (LabCorp) / Integrated Genetics | Leica Biosystems Inc. (a Danaher company) | Leica Microsystems (a Danaher company) | Lifecode | Inc. | MagArray | Inc. | Martell Diagnostic Laboratories | Inc. | Matrix-Bio | Inc. | Mayo Medical Laboratories and Mayo Clinic | Medical & Biological Laboratories Co. | Ltd. (MBL) | MBL International Corporation | MDxHealth SA | Metamark Genetics | Inc. | MetaStat | Inc. | MolecularMD Corporation | Multiplicom NV | Myriad Genetics | Inc. | Myriad RBM | Inc. | NanoIVD | Inc. | NanoString Technologies | Inc. | NeoGenomics | Inc. / NeoGenomics Laboratories | NewGene Ltd. | New Oncology AG | Nuclea Biotechnologies | Inc. | Ohmx Corporation | Omnyx | Oncimmune Ltd. | Oncimmune (USA) LLC (acquired by HDL Inc.) | Health Diagnostic Laboratory | Inc. | OncoCyte Corporation | OncoDNA SA | OncoHealth Corp. | Oncolab | Inc. | Oncolys BioPharma Inc. | Oncompass GmbH | Onconome | Inc. | OncoPlex Diagnostics (OncoPlexDx) | Oncospire Genomics | OPKO Health | Inc. / OPKO Diagnostics | Orion Genomics | Ortho-Clinical Diagnostics | OvaGene Oncology Inc. | Oxford Cancer Biomarkers Ltd. | Oxford Gene Technology | Pacific Edge Limited | Pathway Genomics Corporation | Personal Genome Diagnostics | Inc. | PGXL Laboratories | Phenomenome Discoveries Inc. | Polymedco | Inc. | PreTect AS | PrognosDx Health | Inc. | Provista Diagnostics | Inc. | QIAGEN N.V. | QuanDx | Quanterix Corporation | QuantuMDx Group | Quest Diagnostics | RainDance Technologies | Inc. | Randox Laboratories Ltd | Rarecells SAS | Response Genetics | Inc. | Rheonix | Inc. | RiboMed Biotechnologies | Inc. | Roche | Rosetta Genomics Ltd. | ScheBo-Biotech AG | ScreenCell | Sequenom | Inc. | Siemens Healthcare Diagnostics | Symbiodx | Sysmex Corporation | TeloVISION | LLC | Theranostics Health Inc. | Thermo Fisher Scientific | Inc. | Tosoh Corporation | Tosoh Bioscience | Inc. | Transgenomic | Inc. | TrimGen Corporation | TrovaGene | Inc. | Vela Diagnostics | Ventana Medical Systems | Inc. (member of the Roche Group) | Veracyte | Inc. | Wako Diagnostics | Wako Pure Chemical Industries | Ltd. | | Abbott Diagnostics | IntelligentMDx Alliance | PLEX-ID | Iridica | Histology | Alere Inc. | Beckman Coulter | Inc. / Danaher | Lab Services | Sequencing | Genomics | Information Technology | Becton | Dickinson and Company (BD) | The BD MAX Enterprise | Oncology | HPV | Sequencing | Initiatives | Mass Spectrometry | Flow Spectrometry | Bio-Rad Laboratories | Inc. | Controls | Digital PCR | bioMérieux Inc | Expansion | Oncology | Molecular Strategy | Sequencing Service | Danaher Corporation | General Electric - GE Healthcare | Clarient Diagnostic Services | Inc. | Hologic | Inc. | Product News | The Gen-Probe Business | Panther System | Blood Bank | Quest Contract | QIAGEN N.V. | Personalized Healthcare | Infectious Disease Testing | Transplant Medicine and HAIs | HPV | Companion Diagnostics | Liquid Biopsy/CTC | Instrumentation Base | Rotor-Gene Q – Clinical Diagnostics | Sequencing | Exosomes | Information Technology | Collaborations | Forensics | Roche Diagnostics | New Enterprises | Global Access Program for HIV | Core Molecular Tests | STDs | A POC Enterprise – Liat | Prenatal and cfDNA | HPV | Blood Bank | Liquid Biopsy | Sequencing – Putting the Pieces Together | Siemens Healthcare Diagnostics | Histology | Molecular | Companion Diagnostics | Sequencing | China | Sysmex Corporation | Inostics GmbH | Intraoperative Test | Flow Cytometry | Thermo Fisher Scientific Inc. | Molecular Microbiology | Microbiology IT | Transplant | Quality Control | Mass Spectrometry | EIGHTEEN: COMPANY PROFILES: MAJOR MOLECULAR COMPANIES | Affymetrix Inc. | Agilent Technologies | Agilent in Genomics | PCR | Sequencing | Arrays | Sample Management | Mass Spectrometry | Expansion | Asuragen Inc. | Controls | Sample Collection | Sequencing | BGI | With Complete Genomics | BGI Projects | Cepheid | Hospital Acquired Infections (HAI) | TB | Infectious Diseases | Virology | Oncology | Eiken Chemical Co. | Ltd | Enzo Biochem Inc. | IP Situation | Illumina | Sequencing | Sequencing Kits | Sample Prep | IVD Business | Oncology | HLA Typing | IT | Forensics | CLIA Lab Service | Nanopore Sequencing | Sample to Insight | Making a Market | IP Situation | Life Technologies Corporation | Instrumentation and Applications | Liquid Biopsy | Sequencing | Life Technologies an IVD Company | Partnerships Worldwide | Life and Quidel Develop Diagnostics on the 7500 Fast Dx | Sepsis | HIV | Emerging Pathogens | Bacterial Typing | Personalized Medicine | Forensic | PerkinElmer | Inc. (PE) | Newborn Testing | Prenatal Testing | Sequencing | Mass Spectrometry | Information Technology | China | RainDance Technologies | Inc. | Market Expansion | NINETEEN: COMPANY PROFILES: PARTICIPANTS | AutoGenomics Inc. | Biocartis SA | Connectivity | Instrumentation | Collaborations | Idylla News | DiaSorin S.p.A | EKF Diagnostics Holdings Plc | ELITech Group | Epigenomics | Exosome Diagnostics | Inc. | Fluidigm Corporation | Fujirebio Diagnostics | Inc. | GenMark Diagnostics | Genome Diagnostics BV (GenDx) | Luminex Corporation | Business Expansion | MAGPIX Multiplexing | Next Generation NxTag | Product News | Menarini Diagnostics | Nanostring Technologies | Inc. | Alliances | LDTs | Pacific Biosciences of California | Inc. (PacBio) | Quidel Corporation | Lyra Product Line | Solana Molecular System | AmpliVue Product Line | Savanna (formerly Wildcat) | Acquisitions | Rubicon Genomics | Inc. | Transgenomic | Inc. | Alliances | Lab Services | Diagnostic Tools Division | TrovaGene | Inc. | WaferGen Bio-systems | Inc. | TWENTY: COMPANY PROFILES: GREAT EXPECTATIONS | Genomic Vision | GENOMICA S.A.U. | IncellDx | Inc. | Inivata | IntegenX Inc | Linkage Biosciences | Inc. | Savyon Diagnostics | Selventa | VolitionRx Limited | TWENTY-ONE: COMPANY PROFILES: NEWCOMERS | B Braun CeGaT | LLC | Canon BioMedical | Inc. | DestiNA Genomics Ltd | DiamiR | LLC | Randox Laboratories Ltd. | TWENTY-TWO: COMPANY PROFILES: TEST SERVICE PROVIDERS | 23andMe | What a Difference a Few Years Makes | The Move to Building a Research Company | Therapeutics Group | Ancestry | Outside the U.S. | Adaptive Biotechnologies Corporation | Agendia BV | AltheaDx Diagnostics | Inc. | Ambry Genetics | Oncology | Cardiac | Prenatal | Information Technology | ARUP Laboratories | Assurex Health | Athena Diagnostics | Bio-Reference Laboratories | Inc. (BRLI) | bioTheranostics | Cancer Genetics | Inc. (CGI) | The Response Genetics Acquisition | CareDx | Inc. | Caris Life Sciences | Centogene AG | Complete Genomics | Counsyl | Exact Sciences Corp. | Foundation Medicine Inc. | Genomic Health | Inc. | Market Uptake | Sequencing | Liquid Biopsy | Service Spin Off | Helomics Corporation | IntegraGen | Invitae Corporation | LabCorp | Laboratory Corporation of America | Infectious Diseases | Prenatal | Sequencing | Oncology | BRCA Saga | Information Technology | Forensic | Collaborations | Mayo Medical Laboratories | Information Technology | MDxHealth SA | Myriad Genetics | Product News | Companion Tests | Beyond Cancer | The U.S. Market | IP Update | Pathway Genomics Corporation | Quest Diagnostics | Oncology | Toxicology | Prenatal and Women’s Health | Market Expansion | Quest Partners for Market Accessibility | Rosetta Genomics Ltd. | Expansion | Veracyte | Inc. | TWENTY-THREE: COMPANY PROFILES: POINT OF CARE TEST SPECIALISTS | Atlas Genetics Ltd. | Biomeme | Inc. | DiAssess Inc | DNA Electronics Ltd (DNAe) | Enigma Diagnostics Limited | Entopsis | Epistem Holdings plc | InSilixa Inc. | Lucigen | PositiveID Corporation | QuantuMDx Group Limited | Rheonix | Inc. | Scanogen Inc. | Ubiquitome | Veredus Laboratories Pte Ltd | Xagenic